Items 1 to 25 of 29 total

per page
  1. 1
  2. 2

Set Descending Direction
Catalog No. Product Name Application Product Information


PPAR-α/γ agonist
Aleglitazar is a new dual PPAR-α/γ agonist with IC50 of 2.8 nM/4.6 nM.
A15013 SALE


PPAR-γ partial agonist
Balaglitazone is a novel partial agonist of PPAR-gamma (γ).


PPAR agonist
Bezafibrate is the first clinically tested dual and pan-PPAR co-agonist.
A15836 SALE


PPAR agonist
BMS-687453 is a potent and selective peroxisome proliferator activated receptor (PPAR) alpha agonist, with an EC(50) of 10 nM for human PPARalpha and approximately 410-fold selectivity vs human PPARgamma in PPAR-GAL4 transactivation assays.


PPARγ Agonist
CDDO-Im is a novel synthetic triterpenoid more potent than its parent compound CDDO both in vitro and in vivo; PPARγ Agonist.
A11137 SALE


Peroxisome Proliferator
Cetaben is a unique, PPARα-independent peroxisome proliferator with hypolipidemic activity that inhibits cholesterol synthesis in the human hepatoma Hep-G2 cells resulting in reversible changes in Golgi morphology.
A11727 SALE


Ciprofibrate is a fibrate.

Clofibric Acid

PPARα agonist
Clofibric acid is a PPARα agonist and hypolipidemic agent.

DG172 dihydrochloride

PPARβ/δ inverse agonist
DG-172 is an orally active potent PPARβ/δ inverse agonist (IC50 = 26.9 nM). DG-172 inhibits Angptl4 gene expression in mouse myoblasts (IC50 = 9.5 nM) in vitro.
A15454 SALE


PPAR agonist
Elafibranor is an agonist of the peroxisome proliferator-activated Receptor-α and -δ, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening.


Fenofibrate is a drug of the fibrate class. It is mainly used to reduce cholesterol levels in patients at risk of cardiovascular disease.

Fenofibric acid

Fenofibric acid is a fibrate that acts as a lipid-lowering agent, decreasing low-density lipoprotein cholesterol and triglycerides.
A10424 SALE

Gemfibrozil (Lopid)

Gemfibrozil (Lopid) is a compound used to lower lipid levels.
A12392 SALE

GSK 0660

PPARδ antagonist
GSK 0660 is a selective PPARβ antagonist (IC50 values are 0.155, > 10 and ≥ 10 µM at PPARβ, PPARα and PPARγ respectively).
A12391 SALE


PPAR antagonist
GSK-3787 is a potent and selective peroxisome proliferator-activated receptor δ (PPARδ) antagonist (pIC50 = 6.6).

GW 501516

PPARδ receptor agonist
GW501516 (GW1516 or GSK-516) is a drug that acts as a PPAR?? modulator.

GW 7647

PPARα agonist
GW 7647 is a potent and highly selective PPARα agonist (EC50 values are 6, 1100 and 6200 nM for human PPARα, PPARγ and PPARδ receptors respectively).
A11984 SALE

GW 9662

PPARγ antagonist
GW 9662 is a selective PPARγ antagonist (IC50 values are 3.3, 32 and 2000 nM for PPARγ, PPARα and PPARδ respectively).
A14958 SALE


PPAR agonist
GW0742 is a selective agonist of PPARδ with EC50 value of 1.1 nM.


PPAR agonist
GW1929 is a synthetic peroxisome proliferator-activated receptor-?? (PPAR??) agonist with IC50 of 6.2 nM and 13 nM for human and mouse, respectively.


PPARα antagonist
GW6471 is a PPARα antagonist, shown to completely inhibit GW409544-induced activation of PPARα.

Inolitazone dihydrochloride

PPARγ agonist
Inolitazone dihydrochloride is a novel high-affinity PPARγ agonist, which activates PPARγ with an EC50 about 1/50 that of rosiglitazone and has no effect on RIE cells.
A11983 SALE


PPARδ agonist
L-165,041 is a potent PPARδ agonist (Ki = 6 nM); displays > 100-fold selectivity for both mouse and human PPARδ receptors over other subtypes.
A11680 SALE

Pioglitazone (Actos)

PPARγ agonist
Pioglitazone selectively stimulates the nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR-γ) and to a lesser extent PPAR-α.
A12360 SALE

pirinixic acid (WY 14643)

PPARα agonist
WY 14643 is a highly potent PPARα agonist.

Items 1 to 25 of 29 total

per page
  1. 1
  2. 2

Set Descending Direction